Skip to main content
Top
Published in: Diabetologia 9/2010

01-09-2010 | Research Letter

Nocturnal hypoglycaemia presenting as somnambulism

Author: D. S. H. Bell

Published in: Diabetologia | Issue 9/2010

Login to get access

Excerpt

To the Editor: Somnambulism (sleepwalking) is defined as a parasomnia of non-rapid-eye-movement (NREM) sleep during which movement behaviours that normally only occur in the awake state occur during sleep. Somnambulism is mainly a disease of childhood, but it can occur in adults and may be precipitated by environmental factors such as change in sleep schedule (jet lag) or emotional stress [1]. Use of hypnotics, particularly zolpidem, sedatives, narcoleptics or alcohol can also cause somnambulism. Pathologies such as fever, cardiac arrhythmias, epileptic seizures, asthma, obstructive sleep apnoea and psychiatric conditions have also been reported to precipitate somnambulism [2]. …
Literature
1.
go back to reference Hughes JR (2007) A review of sleepwalking (somnambulism): the enigma of neurophysiology and polysomnography with differential diagnosis of complex partial seizures. Epilepsy Behav 11:483–491CrossRefPubMed Hughes JR (2007) A review of sleepwalking (somnambulism): the enigma of neurophysiology and polysomnography with differential diagnosis of complex partial seizures. Epilepsy Behav 11:483–491CrossRefPubMed
2.
go back to reference Hoque R, Chesson AL Jr (2009) Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. J Clin Sleep Med 5:471–476PubMed Hoque R, Chesson AL Jr (2009) Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. J Clin Sleep Med 5:471–476PubMed
3.
go back to reference Tkacs NC, Pan Y, Sawhney G, Mann GL, Morrison AR (2007) Hypoglycemia activates arousal-related neurons and increases wake time in adult rats. Physiol Behav 91:240–249CrossRefPubMed Tkacs NC, Pan Y, Sawhney G, Mann GL, Morrison AR (2007) Hypoglycemia activates arousal-related neurons and increases wake time in adult rats. Physiol Behav 91:240–249CrossRefPubMed
4.
go back to reference Porter PA, Byrne G, Stick S, Jones TW (1996) Nocturnal hypoglycaemia and sleep disturbances in young teenagers with insulin dependent diabetes mellitus. Arch Dis Child 75:120–123CrossRefPubMed Porter PA, Byrne G, Stick S, Jones TW (1996) Nocturnal hypoglycaemia and sleep disturbances in young teenagers with insulin dependent diabetes mellitus. Arch Dis Child 75:120–123CrossRefPubMed
5.
go back to reference Bendtson I, Gade J, Thomsen CE, Rosenfalck A, Wildschiødtz G (1992) Sleep disturbances in IDDM patients with nocturnal hypoglycemia. Sleep 15:74–81PubMed Bendtson I, Gade J, Thomsen CE, Rosenfalck A, Wildschiødtz G (1992) Sleep disturbances in IDDM patients with nocturnal hypoglycemia. Sleep 15:74–81PubMed
6.
go back to reference Bialasiewicz P, Pawlowski M, Nowak D, Loba J, Czupryniak L (2009) Decreasing concentration of interstitial glucose in REM sleep in subjects with normal glucose tolerance. Diabet Med 26:339–344CrossRefPubMed Bialasiewicz P, Pawlowski M, Nowak D, Loba J, Czupryniak L (2009) Decreasing concentration of interstitial glucose in REM sleep in subjects with normal glucose tolerance. Diabet Med 26:339–344CrossRefPubMed
Metadata
Title
Nocturnal hypoglycaemia presenting as somnambulism
Author
D. S. H. Bell
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1842-5

Other articles of this Issue 9/2010

Diabetologia 9/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.